A detailed history of Aton Ra Partners transactions in Insulet Corp stock. As of the latest transaction made, Aton Ra Partners holds 3,434 shares of PODD stock, worth $903,931. This represents 1.49% of its overall portfolio holdings.

Number of Shares
3,434
Previous 3,712 7.49%
Holding current value
$903,931
Previous $592,000 25.84%
% of portfolio
1.49%
Previous 1.24%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$127.77 - $221.42 $35,520 - $61,554
-278 Reduced 7.49%
3,434 $745,000
Q3 2023

Oct 25, 2023

SELL
$154.67 - $290.89 $22,117 - $41,597
-143 Reduced 3.71%
3,712 $592,000
Q2 2023

Jul 18, 2023

SELL
$272.48 - $330.23 $249,864 - $302,820
-917 Reduced 19.22%
3,855 $1.11 Million
Q1 2023

May 05, 2023

SELL
$276.36 - $326.03 $185,437 - $218,766
-671 Reduced 12.33%
4,772 $1.52 Million
Q4 2022

Feb 02, 2023

SELL
$212.22 - $313.46 $76,186 - $112,532
-359 Reduced 6.19%
5,443 $1.6 Million
Q3 2022

Nov 14, 2022

SELL
$224.6 - $281.45 $104,888 - $131,437
-467 Reduced 7.45%
5,802 $1.33 Million
Q2 2022

Aug 15, 2022

SELL
$186.4 - $279.02 $1.39 Million - $2.08 Million
-7,460 Reduced 54.34%
6,269 $1.37 Million
Q1 2022

May 16, 2022

SELL
$194.8 - $275.7 $901,729 - $1.28 Million
-4,629 Reduced 25.22%
13,729 $3.66 Million
Q4 2021

Feb 14, 2022

BUY
$255.32 - $318.29 $179,489 - $223,757
703 Added 3.98%
18,358 $4.89 Million
Q3 2021

Nov 15, 2021

BUY
$260.36 - $307.27 $554,306 - $654,177
2,129 Added 13.71%
17,655 $5.02 Million
Q2 2021

Aug 12, 2021

SELL
$225.52 - $304.06 $136,214 - $183,652
-604 Reduced 3.74%
15,526 $4.26 Million
Q1 2021

May 17, 2021

SELL
$235.95 - $293.05 $1.46 Million - $1.81 Million
-6,170 Reduced 27.67%
16,130 $4.21 Million
Q4 2020

Feb 19, 2021

BUY
$215.97 - $265.89 $4.82 Million - $5.93 Million
22,300 New
22,300 $5.7 Million

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.3B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Aton Ra Partners Portfolio

Follow Aton Ra Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

News

Stay updated on Aton Ra Partners with notifications on news.